187 related articles for article (PubMed ID: 21499119)
1. Drug exposure in pregnancy and heart defects.
Matok I; Pupco A; Koren G
J Cardiovasc Pharmacol; 2011 Jul; 58(1):20-4. PubMed ID: 21499119
[TBL] [Abstract][Full Text] [Related]
2. Maternal asthma, asthma medication use, and the risk of congenital heart defects.
Lin S; Herdt-Losavio M; Gensburg L; Marshall E; Druschel C
Birth Defects Res A Clin Mol Teratol; 2009 Feb; 85(2):161-8. PubMed ID: 19067406
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant drugs during pregnancy and infant congenital heart defect.
Källén B; Otterblad Olausson P
Reprod Toxicol; 2006 Apr; 21(3):221-2. PubMed ID: 16406480
[No Abstract] [Full Text] [Related]
4. Folic acid antagonists during pregnancy and the risk of birth defects.
Hernández-Díaz S; Werler MM; Walker AM; Mitchell AA
N Engl J Med; 2000 Nov; 343(22):1608-14. PubMed ID: 11096168
[TBL] [Abstract][Full Text] [Related]
5. [Antiepileptic drugs and congenital malformations].
Nakken KO; Lillestølen KM; Brodtkorb E; Svendsen T; Haggag KJ; Taubøll E
Tidsskr Nor Laegeforen; 2014 Jul; 134(12-13):1239-42. PubMed ID: 24989202
[TBL] [Abstract][Full Text] [Related]
6. Congenital heart disease in Southern Brazil: potential impact and prevention.
da Silva JN; Trevisan P; Guimarães VB; Zen TD; da Rosa EB; Silveira DB; Varella-Garcia M; Paskulin GA; Rosa RF; Zen PR
Int J Cardiol; 2015 Jan; 179():9-10. PubMed ID: 25464392
[No Abstract] [Full Text] [Related]
7. Folic acid antagonists during pregnancy and risk of birth defects.
Sharfstein JM
N Engl J Med; 2001 Mar; 344(12):933; author reply 934-5. PubMed ID: 11263426
[No Abstract] [Full Text] [Related]
8. Folic acid antagonists during pregnancy and risk of birth defects.
Amitai Y; Leventhal A
N Engl J Med; 2001 Mar; 344(12):933; author reply 934-5. PubMed ID: 11263425
[No Abstract] [Full Text] [Related]
9. Valproic acid monotherapy in pregnancy and major congenital malformations.
Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT;
N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369
[TBL] [Abstract][Full Text] [Related]
10. Folic acid antagonists during pregnancy and risk of birth defects.
Brentlinger PE
N Engl J Med; 2001 Mar; 344(12):933-4; author reply 934-5. PubMed ID: 11263424
[No Abstract] [Full Text] [Related]
11. First-trimester exposure to bupropion and risk of cardiac malformations.
Louik C; Kerr S; Mitchell AA
Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1066-75. PubMed ID: 24920293
[TBL] [Abstract][Full Text] [Related]
12. Severe fetal valproate syndrome: combination of complex cardiac defect, multicystic dysplastic kidney, and trigonocephaly.
Ozkan H; Cetinkaya M; Köksal N; Yapici S
J Matern Fetal Neonatal Med; 2011 Mar; 24(3):521-4. PubMed ID: 21291342
[TBL] [Abstract][Full Text] [Related]
13. Nongenital malformations following exposure to progestational drugs: the last chapter of an erroneous allegation.
Brent RL
Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):906-18. PubMed ID: 16206282
[TBL] [Abstract][Full Text] [Related]
14. Folic acid and methionine in the prevention of teratogen-induced congenital defects in mice.
Cipollone D; Carsetti R; Tagliani A; Rosado MM; Borgiani P; Novelli G; D'Amati G; Fumagalli L; Marino B; Businaro R
Cardiovasc Pathol; 2009; 18(2):100-9. PubMed ID: 18417366
[TBL] [Abstract][Full Text] [Related]
15. Maternal drugs and congenital heart disease.
Zierler S
Obstet Gynecol; 1985 Feb; 65(2):155-65. PubMed ID: 3881709
[TBL] [Abstract][Full Text] [Related]
16. Moderate use of alcohol, tobacco and cannabis during pregnancy: new approaches and update on research findings.
Huizink AC
Reprod Toxicol; 2009 Sep; 28(2):143-51. PubMed ID: 19394419
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular birth defects and prenatal exposure to female sex hormones: importance of utilizing proper epidemiological methods and teratologic principles.
Brent RL
Teratology; 1994 Mar; 49(3):159-61. PubMed ID: 8059420
[No Abstract] [Full Text] [Related]
18. Exposure during pregnancy to glycol ethers and chlorinated solvents and the risk of congenital malformations.
Cordier S; Garlantézec R; Labat L; Rouget F; Monfort C; Bonvallot N; Roig B; Pulkkinen J; Chevrier C; Multigner L
Epidemiology; 2012 Nov; 23(6):806-12. PubMed ID: 23007043
[TBL] [Abstract][Full Text] [Related]
19. Antiepileptic drug regimens and major congenital abnormalities in the offspring.
Samrén EB; van Duijn CM; Christiaens GC; Hofman A; Lindhout D
Ann Neurol; 1999 Nov; 46(5):739-46. PubMed ID: 10553991
[TBL] [Abstract][Full Text] [Related]
20. Errata in "Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the norwegian mother and child cohort study".
Nezvalová-Henriksen K; Spigset O; Nordeng HM
Headache; 2012 Sep; 52(8):1319-20. PubMed ID: 22946832
[No Abstract] [Full Text] [Related]
[Next] [New Search]
